期刊文献+

趋化因子受体3及其配体在眼部疾病中的作用

Research progress in chemokine receptor 3 and its ligands in ophthalmology
下载PDF
导出
摘要 趋化因子受体3 (CCR3)及其配体eotaxin是一种与哮喘和过敏相关的炎性因子,研究发现CCR3及其配体与多种眼科疾病相关,如脉络膜新生血管、变态反应性结膜炎、视网膜中央静脉阻塞、年龄相关性黄斑变性、视网膜变性等.CCR3的生物学功能研究认为,CCR3及其配体eotaxin不仅参与促进嗜酸性粒细胞与肥大细胞的运输,还参与炎症反应过程,了解其在眼部疾病发生及发展过程中的作用对于眼科相关疾病的认识和诊治有重要意义.就CCR3及其配体的结构和生物学功能以及其与一些眼部疾病的关系进行综述. Chemokine receptor 3 (CCR3) and its ligands eotaxin are inflammatory factors,and they were thought to be related to asthma and allergic diseases before.Recent studies showed that CCR3 plays significant roles in many eye diseases,such as choroidal noevascularization (CNV),allergic cunjunctivititis,age-related macular degeneration (AMD),central retinal vein occlusion and retinal degeneration etc.The biological function study suggested that CCR3 and eotaxin participate in not only promoting the transportation of eosinophilic granulocyte and mastocyte but also inflammatory response.To understand the roles of CCR3 and eotaxin in eye diseases has a very important significance for the recognition and treatment of eye diseases.The structure and function of CCR3 and its ligands,and the relationship between CCR3 and some eye diseases were reviewed.
出处 《中华实验眼科杂志》 CAS CSCD 北大核心 2014年第3期270-273,共4页 Chinese Journal Of Experimental Ophthalmology
基金 国家重点基础研究发展计划项目(2011CB510200) 国家自然科学基金项目(81271023)
关键词 趋化因子受体3 配体 脉络膜新生血管 眼科 Chemokine receptor 3 Eotaxin Choroidal noevascularization Ophthalmology
  • 相关文献

参考文献4

二级参考文献49

  • 1XIEZheng-fu SHIHuan-zhong QINXue-jun KANGLan-fu HUANGChun-ping CHENYi-qiang.Effects of antigen presentation of eosinophils on lung Th1/Th2 imbalance[J].Chinese Medical Journal,2005(1):6-11. 被引量:5
  • 2李林,司马晶,周月芷,窦晓燕,孔庆慧.眼压和轴长在视网膜中央静脉阻塞中的意义[J].临床眼科杂志,2005,13(2):109-111. 被引量:4
  • 3于强,许京京,朱斯平,柳青.广东省斗门县老年黄斑变性流行病学调查[J].中华眼底病杂志,1994,10(2):115-116. 被引量:14
  • 4Klein R,Klein BE,Moss SE,et al.The epidemiology of retinal vein occlusion:the Beaver Dam Eye Study.Trans Am Ophthalmol Soc,2000,98:133-141.
  • 5Mitchell P,SmithW,Chang A.Prevalence and associations of retinal vein occlusion in Australia.The Blue Mountains Eye Study.Arch Ophthalmol,1996,114:1243-1247.
  • 6Zimmermann M,Seifert V.Endothelin and Subarachnoid Hemorrhage:an Overview.Neurosurgery,1998,4:863-875.
  • 7Donati G,Pournaras C J,Tsacopoulos M.Effec of Nitroprusside on Arteriolar Constriction After Retina Branch Vein Occlusion.Invest Ophthalmol Vis Sci,1998,39:1910-1917.
  • 8Iannaccone A,Letizia C,Pazzaglia S,et al.Plasma Endothelin-1 Concentrations in Patients with Retinal Vein Occlusions.Br J Ophthalmol,1998,82:498-503.
  • 9Vine AK.Hyperhomocysteinemia:a risk factor for central retinal vein occlusion.Am J Ophthalmol,2000,129:640-644.
  • 10Marcucci R,Giusti B,Betti I,et al.Genetic determinants of fasting and post-methionine hyperhomocysteinemia in patients with retinal vein occlusion.Thromb Res,2003,110:7-12.

共引文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部